Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 4 Open-market sale President & GM China sold 4,000 shares at $300.00 ($1,200,000)
  2. 4 Open-market sale CFO & Chief Strategy Officer sold 14,000 shares at an average $299.60 ($4,194,413)
  3. 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $280.38 ($420,568)
  4. 4 Open-market sale Chief Executive Officer sold 54,303 shares at an average $280.39 ($15,226,093)
  5. 4 Open-market sale Director sold 5,000 shares at an average $280.42 ($1,402,116)
  6. 4 Open-market sale President & GM China sold 4,000 shares at $280.35 ($1,121,406)
  7. 4 Open-market sale Director sold 5,000 shares at an average $260.27 ($1,301,356)
  8. 4 Open-market sale President & GM China sold 4,000 shares at an average $260.33 ($1,041,327)
  9. 4 Open-market sale Chief Executive Officer sold 81,228 shares at an average $253.46 ($20,587,969)
  10. 4 Open-market sale CFO & Chief Strategy Officer sold 14,000 shares at an average $250.27 ($3,503,764)
  11. 4 Open-market sale CMO, Hematology sold 3,128 shares at an average $233.07 ($729,045)
  12. 4 Open-market sale Chief Executive Officer sold 61,042 shares at an average $233.21 ($14,235,597)
  13. 4 Open-market sale CMO, Hematology sold 3,000 shares at an average $242.21 ($726,626)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award 10% owner acquired 59,390 shares (grant or award)
  17. 4 Grant or award 10% owner acquired 123,566 shares (grant or award)
  18. 4 Open-market sale Chief Executive Officer sold 92,177 shares at an average $237.06 ($21,851,789)
  19. 4 Grant or award 10% owner acquired 168,352 shares (grant or award)
  20. 4 Open-market sale Chief Executive Officer sold 42,968 shares at an average $212.71 ($9,139,562)

Page 18 of 29 · 580 filings